PolyPeptide Group AG (SWX: PPGN)
Switzerland
· Delayed Price · Currency is CHF
32.25
-0.80 (-2.42%)
Sep 4, 2024, 5:30 PM CET
PolyPeptide Group AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 20.57 | 17.3 | 52.73 | 31.7 | 33.47 | 17.16 | |
Accounts Receivable | 1.46 | 0.81 | 1.81 | 0.25 | 0.32 | 1.56 | |
Other Receivables | 8.26 | 4.73 | 5.42 | 6.91 | 9.28 | 9.31 | |
Property, Plant & Equipment | 1,428 | 1,372 | 1,324 | 1,342 | 1,279 | 1,267 | |
Other Intangible Assets | - | - | - | - | 0 | 0.01 | |
Long-Term Deferred Tax Assets | 0.18 | 0.24 | 0.2 | 0.16 | 0.16 | 0.15 | |
Current Income Taxes Payable | 1.75 | 5.76 | 10.76 | 12.26 | 18.22 | 6.53 | |
Common Stock | 19 | 19 | 19 | 19 | 19 | 19 | |
Retained Earnings | 879.19 | 877.19 | 886.86 | 788.78 | 692.04 | 660.65 | |
Treasury Stock | -35.77 | -35.77 | -35.79 | -0.63 | - | -9.98 | |
Total Liabilities & Equity | 1,469 | 1,400 | 1,456 | 1,427 | 1,378 | 1,343 | |
Total Debt | 460.47 | 382.39 | 394.89 | 435.33 | 475.57 | 516.26 | |
Net Cash (Debt) | -439.89 | -365.09 | -342.16 | -403.63 | -442.1 | -499.1 | |
Net Cash Per Share | -47.73 | -39.61 | -36.78 | -42.49 | -47.02 | -52.48 | |
Filing Date Shares Outstanding | 9.22 | 9.22 | 9.22 | 9.49 | 9.5 | 9.4 | |
Total Common Shares Outstanding | 9.22 | 9.22 | 9.22 | 9.49 | 9.5 | 9.4 | |
Book Value Per Share | 94.28 | 94.09 | 95.34 | 85.28 | 74.80 | 70.87 | |
Tangible Book Value | 869.02 | 867.31 | 878.81 | 809.74 | 710.63 | 666.13 | |
Tangible Book Value Per Share | 94.28 | 94.09 | 95.34 | 85.28 | 74.80 | 70.87 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.